• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original PMA or panel track supplement and may not represent the most recent labeling.
 
DeviceMEDTRONIC MICRA TRANSCATHETER PACEMAKER SYSTEM
Generic NameLeadless pacemaker
Regulation Number870.3610
ApplicantMEDTRONIC Inc.
8200 CORAL SEA STREET NE
MS MV S11
MOUNDS VIEW, MN 55112
PMA NumberP150033
Date Received09/17/2015
Decision Date04/06/2016
Product Code PNJ 
Docket Number 16M-1125
Notice Date 04/12/2016
Advisory Committee Cardiovascular
Clinical TrialsNCT02004873
Expedited Review Granted? Yes
Combination ProductYes
RecallsCDRH Recalls
Approval Order Statement  
Approval for the Micra Transcatheter Pacemaker System (Pacemaker Model MC1VR01 and Programmer Application Software model SW022 Version 1.1). This device is indicated for use in patients who have experienced one or more of the following conditions:• symptomatic paroxysmal or permanent high-grade AV block in the presence of AF• symptomatic paroxysmal or permanent high-grade AV block in the absence of AF, as an alternative to dual chamber pacing, when atrial lead placement is considered difficult, high risk, or not deemed necessary for effective therapy• symptomatic bradycardia-tachycardia syndrome or sinus node dysfunction (sinus bradycardia or sinus pauses), as an alternative to atrial or dual chamber pacing, when atrial lead placement is considered difficult, high risk, or not deemed necessary for effective therapyRate-responsive pacing is indicated to provide increased heart rate appropriate to increasing levels of activity.
Approval OrderApproval Order
SummarySummary of Safety and Effectiveness
LabelingLabeling
Labeling Part 2
Post-Approval StudyShow Report Schedule and Study Progress
Supplements:  S001 S002 S003 S005 S006 S013 S014 S021 S022 S007 S008 
S009 S010 S024 S025 S004 S015 S016 S017 S018 S019 S020 S011 
S012 S023 S038 S039 S040 S033 S055 S069 S070 S071 S072 S073 
S074 S051 S052 S053 S054 S085 S062 S063 S097 S098 S099 S100 
S101 S102 S103 S136 S137 S138 S140 S141 S162 S163 S164 S118 
S119 S120 S121 S122 S123 S124 S125 S126 S127 S090 S091 S166 
S167 S168 S169 S170 S171 S026 S031 S032 S028 S029 S030 S034 
S035 S036 S027 S041 S042 S047 S075 S076 S077 S048 S049 S050 
S056 S057 S058 S059 S060 S061 S064 S065 S086 S066 S067 S068 
S043 S044 S045 S046 S078 S079 S080 S081 S082 S083 S084 S149 
S150 S151 S152 S153 S154 S155 S131 S132 S133 S134 S107 S108 
S109 S110 S111 S172 S173 S174 S165 S092 S093 S094 S095 S096 
S156 S157 S158 S159 S160 S161 S142 S143 S144 S145 S146 S147 
S148 S104 S105 S106 S087 S088 S089 S135 S130 S128 S129 S112 
S113 S114 S115 S116 S181 S182 S186 S187 S183 S184 S175 S176 
S177 S178 S179 S180 
-
-